While KISIMA—VSV-GP-TAg vaccination induced a strong tumor infiltration of NKG2A+ antigen-specific CD8 T cells, only limited tumor infiltration of NK cells and no up-regulation of NKG2A expression was observed, suggesting that combination effect could rely mainly on CD8 T cells. The gene discussed is KLRC1; the disease is neoplasm.